compound, pharmaceutical composition, use of the compound, and methods for treating mglur5-mediated disorders and inhibiting activation of mglur5 receptors

• 收藏
• 分享

专利权人:

ASTRAZENECA AB

发明人:

Abdelmalik Slassi,Alexander Minidis,Guang-ri Sun,Louise Edwards,Methvin Isaac,Peter Dove,Tao Xin

申请号：

BRPI0614480

公开号：

BRPI0614480A2

申请日:

2006.08.04

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar<；SUB>；1<；/SUB>；, A, Hy, R<；SUB>；1<；/SUB>；, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses of, and processes of making the compounds, as well as methods of medical treatment of mGluR5-mediated disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/